Depression medication list
Pro Research Analysisby 
Searched over 200M research papers
Comprehensive List of Depression Medications
Introduction to Depression Medications
Depression is a prevalent mental health disorder that significantly impacts individuals' quality of life. The treatment landscape for depression includes a variety of medications, each with distinct mechanisms of action and efficacy profiles. This article provides an overview of the primary classes of antidepressants, emerging drugs, and experimental treatments for depression.
First-Line Antidepressants: SSRIs and SNRIs
Selective Serotonin Reuptake Inhibitors (SSRIs)
SSRIs are the most commonly prescribed antidepressants due to their favorable side effect profile and efficacy. Medications in this class include sertraline, fluoxetine, and citalopram. SSRIs work by increasing serotonin levels in the brain, which helps improve mood and reduce symptoms of depression 39.
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
SNRIs, such as venlafaxine and desvenlafaxine, are another first-line treatment option. These medications increase both serotonin and norepinephrine levels, providing a broader mechanism of action compared to SSRIs. SNRIs are particularly useful for patients who do not respond adequately to SSRIs 45.
Older Antidepressants: TCAs and MAOIs
Tricyclic Antidepressants (TCAs)
TCAs, including amitriptyline and nortriptyline, are effective but often reserved for treatment-resistant cases due to their side effect profile. These medications work by inhibiting the reuptake of serotonin and norepinephrine but are associated with more severe side effects compared to newer antidepressants 48.
Monoamine Oxidase Inhibitors (MAOIs)
MAOIs, such as phenelzine and tranylcypromine, are another older class of antidepressants. They are particularly effective for atypical depression but require dietary restrictions and have significant drug interactions, limiting their use 48.
Newer and Emerging Antidepressants
Trazodone-ER, Desvenlafaxine, and Vilazodone
Recent additions to the antidepressant market include trazodone-ER, desvenlafaxine, and vilazodone. These medications offer new mechanisms of action and improved tolerability, addressing some of the limitations of older antidepressants .
Augmentation Agents: Aripiprazole and Quetiapine
Aripiprazole and quetiapine are antipsychotic medications approved as augmentation agents for depression. They are used in combination with other antidepressants to enhance therapeutic effects, particularly in treatment-resistant cases .
Experimental and Novel Treatments
Glutamatergic Modulation: Ketamine
Ketamine, an NMDA receptor antagonist, has shown promise in rapidly reducing depressive symptoms, especially in treatment-resistant depression. Its unique mechanism of action offers hope for patients who do not respond to traditional antidepressants 12.
Other Novel Mechanisms
Research is ongoing into medications that target cholinergic, opioid, sigma, and neurokinin receptors, among others. These novel approaches aim to provide faster and more effective relief from depressive symptoms with fewer side effects 12.
Off-Label Uses of Antidepressants
Antidepressants are also prescribed off-label for various conditions, including anxiety disorders, chronic pain, and sleep disturbances. This practice highlights the versatility of these medications beyond their primary indication for depression .
Conclusion
The landscape of depression treatment is continually evolving, with new medications and experimental treatments offering hope for improved outcomes. While SSRIs and SNRIs remain the first-line treatments due to their efficacy and tolerability, ongoing research into novel mechanisms of action promises to address the unmet needs in depression therapy.
Sources and full results
Most relevant research papers on this topic
Use of Antidepressants among Patients Diagnosed with Depression: A Scoping Review
Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed antidepressant for depression due to their better side effects and tolerability profile compared to other drugs.
Patterns of Antidepressant Prescriptions for the Treatment of Depression: A Scoping Review
Selective serotonin reuptake inhibitors (SSRIs) are the most preferred antidepressant for depression treatment due to their better side effect and tolerability profile compared to other drugs.
DOI